Frequently Asked Questions
The market is segmented based on Global Endoscopic Retrograde Cholangiopancreatography (ERCP) and Percutaneous Transhepatic Cholangiography (PTC) Devices Market, By Product Type (Sphincterotomes, Lithotripter, Endoscopes, Accessories, Stents, Cannulas, Forceps, Snares, Catheters, Guiding Wires, Balloons, Baskets, Others), Application (Jaundice, Stone Removal, Postoperative or Posttraumatic Bile Leakage, Pancreatitis, Others), End-User (Hospitals, Specialty Clinics, Diagnostic Laboratories, Others) - Industry Trends and Forecast to 2030.
.
The Global Endoscopic Retrograde Cholangiopancreatography And Percutaneous Transhepatic Cholangiography Devices Market size was valued at USD 524.65 USD Million in 2022.
The Global Endoscopic Retrograde Cholangiopancreatography And Percutaneous Transhepatic Cholangiography Devices Market is projected to grow at a CAGR of 3.22% during the forecast period of 2023 to 2030.
The major players operating in the market include OLYMPUS CORPORATION, CONMED Corporation, TeleMed Systems, Boston Scientific Corporation, Cook, Merit Medical Systems, KARL STORZ SE & Co. KG, Braun Melsungen AG, BD, FUJIFILM Corporation, Medtronic, HOBBS MEDICAL, SureCare, Richard Wolf GmbH, PENTAX Medical, Johnson & Johnson, Stryker Corporation, Smith & Nephew plc, Karl Storz Endoscopy, Olympus Medical Systems.
The market report covers data from the U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, (Japan), China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
